China (R)-1-Boc-3 Factory

We depend on sturdy technical force and continually create sophisticated technologies to meet the demand of (R)-1-Boc-3,CAS NO 143900-43-0,143900-43-0,Ibrutinib intermediate,Ibrutinib advance intermediate, Top quality, timely company and Aggressive cost, all win us a superior fame in xxx field despite the international intense competition.
(R)-1-Boc-3, We strongly believe that technology and service is our base today and quality will create our reliable walls of future. Only we have better and better quality , could we achieve our customers and ourselves, too. Welcome customers all over the word to contact us for getting further business and reliable relationships. We are always here working for your demands whenever you need.

Hot Products

  • 3,5-Difluorochlorobenzene

    3,5-Difluorochlorobenzene

    Product Name:3,5-Difluorochlorobenzene
    Molecular Formula:C6H3ClF2
    Molecular Weight:148.54
    CAS Registry Number:1435-43-4
  • (S)-(+)-N-(2,3-Epoxypropyl)Phthalimide

    (S)-(+)-N-(2,3-Epoxypropyl)Phthalimide

    (S)-(+)-N-(2,3-Epoxypropyl)Phthalimide
    Molecular FormulaC₁₁H₉NO₃
    Melting Point:101-103°C
    Molecular Weight:203.19
    CAS NO:161596-47-0
    Usage:Rivaroxaban Intermediates​
  • D-Cycloserine

    D-Cycloserine

    Product Name:D-Cycloserine
    Molecular Formula:C3H6N2O2
    Molecular Weight:102.09
    CAS Registry Number:68-41-7
  • Vindesine sulfate

    Vindesine sulfate

    Product Name:Vindesine sulfate
    Molecular Formula:C43H57N5O11S
    Molecular Weight;852
    CAS Registry Number;59917-39-4
  • Canagliflozin

    Canagliflozin

    Product Name:Canagliflozin
    Molecular Formula:C24H25FO5S
    Molecular Weight;444.52
    CAS Registry Number;842133-18-0
  • 1,4-Dioxane

    1,4-Dioxane

    Product Name:1,4-Dioxane
    Molecular Formula:C4H8O2
    Molecular Weight:88.11
    CAS Registry Number:123-91-1

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept